People
Appointment reflects Glauconix Biosciences’ readiness to expand their commercial footprint and business verticals in the field of ophthalmology and beyond
Summit Therapeutics plc a leader in new mechanism antibiotic innovation, announces that Valerie Andrews, a Non-Executive Director, is stepping down from the board of the Company.
Prominence of Scientific Advisory Board and Company Advisory Board signals attraction to xCures’ novel patient-centric approach to treatment and continuous learning for advanced cancer
Will Remain in his Role Until His Successor is Selected and for a Transition Period
Roche Vice Chairman Andre Hoffman is warning that short-term thinking is killing the planet and that corporations must engage in long-term sustainable strategies that limit any environmental harm and can help reverse some of the damage that’s already been done.
Lotus Clinical Research announced that Neil Singla, MD, Chief Scientific Officer spoke at Arrowhead’s Pain & Migraine Therapeutics Summit in Washington, D.C. on Sept. 23, 2019.
N-SIDE, a global software consulting company specializing in advanced analytics technologies, is pleased to welcome Wade Wirta as US Managing Director.
Peter Embí, M.D., M.S., president and chief executive officer of Regenstrief Institute, has been named to the National Advisory Council for the Agency for Healthcare Research and Quality .
During his 14-year tenure as head of BIO, Greenwood oversaw a significant growth at the organization, more than tripling its size to 176 employees with an 85 million operating budget.
NBE-Therapeutics AG, a biopharmaceutical company developing best-in-class, immune-stimulatory antibody drug conjugates (iADCs™), announces the appointment of Dr. Steffen Heeger as Chief Medical Officer (CMO).
PRESS RELEASES